Pi3kca-mutant Breast Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-03-16
Clinical Trial Update: Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients [Phase 1]
Phase 1 trial evaluating the combination of ipatasertib, pertuzumab, and trastuzumab in advanced HER2-positive, PI3KCA-mutant metastatic bre…